| Lipid metabolic reprogramming in cancer cells S Beloribi-Djefaflia, S Vasseur, F Guillaumond Oncogenesis 5 (1), e189-e189, 2016 | 1251 | 2016 |
| Differential control of Bmal1 circadian transcription by REV-ERB and ROR nuclear receptors F Guillaumond, H Dardente, V Giguère, N Cermakian Journal of biological rhythms 20 (5), 391-403, 2005 | 892 | 2005 |
| Strengthened glycolysis under hypoxia supports tumor symbiosis and hexosamine biosynthesis in pancreatic adenocarcinoma F Guillaumond, J Leca, O Olivares, MN Lavaut, N Vidal, P Berthezène, ... Proceedings of the National Academy of Sciences 110 (10), 3919-3924, 2013 | 400 | 2013 |
| Cholesterol uptake disruption, in association with chemotherapy, is a promising combined metabolic therapy for pancreatic adenocarcinoma F Guillaumond, G Bidaut, M Ouaissi, S Servais, V Gouirand, O Olivares, ... Proceedings of the National Academy of Sciences 112 (8), 2473-2478, 2015 | 374 | 2015 |
| The circadian clock component BMAL1 is a critical regulator of p21WAF1/CIP1 expression and hepatocyte proliferation A Gréchez-Cassiau, B Rayet, F Guillaumond, M Teboul, F Delaunay Journal of Biological Chemistry 283 (8), 4535-4542, 2008 | 356 | 2008 |
| Collagen-derived proline promotes pancreatic ductal adenocarcinoma cell survival under nutrient limited conditions O Olivares, JR Mayers, V Gouirand, ME Torrence, T Gicquel, L Borge, ... Nature communications 8 (1), 16031, 2017 | 345 | 2017 |
| Pancreatic adenocarcinoma therapeutic targets revealed by tumor-stroma cross-talk analyses in patient-derived xenografts R Nicolle, Y Blum, L Marisa, C Loncle, O Gayet, V Moutardier, O Turrini, ... Cell reports 21 (9), 2458-2470, 2017 | 163 | 2017 |
| Kruppel-like factor KLF10 is a link between the circadian clock and metabolism in liver F Guillaumond, A Gréchez-Cassiau, M Subramaniam, S Brangolo, ... Molecular and cellular biology 30 (12), 3059-3070, 2010 | 127 | 2010 |
| Influence of the tumor microenvironment on cancer cells metabolic reprogramming V Gouirand, F Guillaumond, S Vasseur Frontiers in oncology 8, 117, 2018 | 126 | 2018 |
| Ultrastructural plasticity in the rat suprachiasmatic nucleus. Possible involvement in clock entrainment D Becquet, C Girardet, F Guillaumond, AM François‐Bellan, O Bosler Glia 56 (3), 294-305, 2008 | 126 | 2008 |
| Minireview: the nuclear hormone receptor family round the clock M Teboul, F Guillaumond, A Gréchez-Cassiau, F Delaunay Molecular Endocrinology 22 (12), 2573-2582, 2008 | 108 | 2008 |
| LIF drives neural remodeling in pancreatic cancer and offers a new candidate biomarker C Bressy, S Lac, J Nigri, J Leca, J Roques, MN Lavaut, V Secq, ... Cancer research 78 (4), 909-921, 2018 | 101 | 2018 |
| Influence of the corticosterone rhythm on photic entrainment of locomotor activity in rats D Sage, J Ganem, F Guillaumond, G Laforge-Anglade, ... Journal of biological rhythms 19 (2), 144-156, 2004 | 99 | 2004 |
| Stromal SLIT2 impacts on pancreatic cancer-associated neural remodeling V Secq, J Leca, C Bressy, F Guillaumond, P Skrobuk, J Nigri, S Lac, ... Cell Death & Disease 6 (1), e1592-e1592, 2015 | 63 | 2015 |
| Pancreatic tumor cell metabolism: focus on glycolysis and its connected metabolic pathways F Guillaumond, JL Iovanna, S Vasseur Archives of biochemistry and biophysics 545, 69-73, 2014 | 60 | 2014 |
| How nuclear receptors tell time M Teboul, A Gréchez-Cassiau, F Guillaumond, F Delaunay Journal of Applied Physiology 107 (6), 1965-1971, 2009 | 60 | 2009 |
| Lipids in cancer: A global view of the contribution of lipid pathways to metastatic formation and treatment resistance S Vasseur, F Guillaumond Oncogenesis 11 (1), 46, 2022 | 52 | 2022 |
| TAp73 loss favors Smad-independent TGF-β signaling that drives EMT in pancreatic ductal adenocarcinoma AK Thakur, J Nigri, S Lac, J Leca, C Bressy, P Berthezene, L Bartholin, ... Cell Death & Differentiation 23 (8), 1358-1370, 2016 | 49 | 2016 |
| Consequences of DJ-1 upregulation following p53 loss and cell transformation S Vasseur, S Afzal, R Tomasini, F Guillaumond, J Tardivel-Lacombe, ... Oncogene 31 (5), 664-670, 2012 | 49 | 2012 |
| Defects in mitophagy promote redox‐driven metabolic syndrome in the absence of TP 53 INP 1 M Seillier, L Pouyet, P N'Guessan, M Nollet, F Capo, F Guillaumond, ... EMBO molecular medicine 7 (6), 802-818, 2015 | 46 | 2015 |
